HomeSearchRARE DISEASE AND ORPHAN DRUGS JOURNAL

RARE DISEASE AND ORPHAN DRUGS JOURNAL

OAE PUBLISHING INC · US · Est. 2021

ISSN2771-2893eISSN2771-2893
SJR Q3WOS ESCIScopus / SJR
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

Find the journal’s official page ↗Open the official JCR record on Clarivate ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

📊 Standing in its field
Where this journal ranks among others in the same subject area.
Q3
SJR · Scopus
Top 75% in field
Clarivate’s JCR quartile is a separate ranking and may differ
SJR Scorei
0.385
H-Indexi
8
Total Worksi
125
Total Citationsi
324
2yr Mean Citednessi
1.43
Open Impact Factor alternative

Aims & Scope

Subject areas: Genetics & Heredity; Pharmacology & Pharmacy; Genetics (clinical); Internal Medicine.

General Information

Country / RegionUS
Primary Language
1st Year Published2021
Annual Volume~ 32 articles / year
StatusActive (last: 2026)
Total Publications125

Submission Info

Peer Review
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

4/11 · 36%
Do you know the journal / publisher?
OAE PUBLISHING INC
Does the journal have a website?
No URL
Is the ISSN verified?
2771-2893 / 2771-2893
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
5
18
2021
13
87
2022
28
137
2023
33
121
2024
35
20
2025
29
0
2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Genetics (clinical)Q3
Internal MedicineQ3

Subject Classification

Web of Science Categories

Genetics & HeredityPharmacology & Pharmacy

Research Topics (OpenAlex)

Genomics and Rare DiseasesLysosomal Storage Disorders ResearchHealth Systems, Economic Evaluations, Quality of LifeSystemic Lupus Erythematosus ResearchGlycogen Storage Diseases and MyoclonusCRISPR and Genetic EngineeringAutism Spectrum Disorder ResearchMuscle Physiology and DisordersVirus-based gene therapy researchCellular transport and secretion

Frequently asked questions about RARE DISEASE AND ORPHAN DRUGS JOURNAL

Is RARE DISEASE AND ORPHAN DRUGS JOURNAL a predatory journal?

PubScope has no integrity flags on record for RARE DISEASE AND ORPHAN DRUGS JOURNAL: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of RARE DISEASE AND ORPHAN DRUGS JOURNAL?

RARE DISEASE AND ORPHAN DRUGS JOURNAL is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.43.

Is RARE DISEASE AND ORPHAN DRUGS JOURNAL indexed in Scopus and Web of Science?

RARE DISEASE AND ORPHAN DRUGS JOURNAL is indexed in Web of Science, Scopus.

What is the aims and scope of RARE DISEASE AND ORPHAN DRUGS JOURNAL?

Subject areas: Genetics & Heredity; Pharmacology & Pharmacy; Genetics (clinical); Internal Medicine.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref